Lancashire and South Cumbria
Formulary
Formulary
7 Obstetrics, Gynaecology, and urinary-tract disorders
07-03-02-03 Intra-uterine progestogen-only contraceptive
| Intrauterine-Progesterone Levonorgestrel IUD Jaydess® |
|
Formulary
|
Intra-uterine device system 13.5mg |
 LSCMMG: Levonorgestrel |
|
| Intrauterine-Progesterone Levonorgestrel IUD Kyleena® |
|
Formulary
|
Intra-uterine device system 19.5mg Consider in nulliparous patients. Effective for 5 years. |
|
|
Links
- FSRH Clinical Guideline: Contraceptive Choices for Young People
- FSRH Statement: Glucagon-like peptide-1 (GLP-1) agonists and oral contraception
- FSRH: Intrauterine Contraception
- FSRH: Standards & Guidance
- FSRH: UK Medical Eligibility Criteria for Contraceptive Use (UKMEC)
LSCMMG: Erectile Dysfunction Guideline- LSCMMG: Levonorgestrel
- LSCMMG: Overactive bladder in female adults
- MHRA: Intrauterine contraception: uterine perforation—updated information on risk factors
- MHRA: Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed?
- NICE CG30: Long-acting reversible contraception
- NICE CG97: Lower urinary tract symptoms in men: management
- NICE NG123: Urinary incontinence and pelvic organ prolapse in women: management
- NICE NG133: Hypertension in pregnancy: diagnosis and management
- NICE NG194: Postnatal care
- NICE NG210: Pelvic floor dysfunction: prevention and non-surgical management
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period
- NICE NG88: Heavy menstrual bleeding: assessment and management